Massachusetts General Hospital SAFER criteria for clinical trials and research.

Antidepressive Agents/pharmacology; Clinical Trials as Topic/methods/standards; Depressive Disorder, Major/diagnosis/therapy; Diagnostic and Statistical Manual of Mental Disorders; Eligibility Determination/methods; Humans; Interview, Psychological/methods/standards; Massachusetts; Patient Selection; Psychiatric Status Rating Scales; Psychological Techniques

Disciplines :

Psychiatry

Author, co-author :

Desseilles, Martin ; Université de Liège - ULiège

Witte, Janet

Chang, Trina E.

Iovieno, Nadia

Dording, Christina

Ashih, Heidi

Nyer, Maren

Freeman, Marlene P.

Fava, Maurizio

Mischoulon, David

Language :

English

Title :

Massachusetts General Hospital SAFER criteria for clinical trials and research.

Publication date :

2013

Journal title :

Harvard Review of Psychiatry

ISSN :

1067-3229

eISSN :

1465-7309

Publisher :

Brunner - Routledge, United States - Pennsylvania

Volume :

Issue :

Pages :

269-74

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 14 January 2016

Statistics

Number of views

294 (0 by ULiège)

Number of downloads

1033 (1 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Greenberg PE, Kessler RC, Birnbaum HG, et al. The economic burden of depression in the United States: how did it change between 1990 and 2000? J Clin Psychiatry 2003;64:1465-75.
Greenberg PE, Stiglin LE, Finkelstein SN, Berndt ER. The economic burden of depression in 1990. J Clin Psychiatry 1993;54:405-18.
Fava M. Diagnosis and definition of treatment-resistant depression. Biol Psychiatry 2003;53:649-59.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Washington, DC: American Psychiatric Press, 2013.
Targum SD, Pollack MH, Fava M. Redefining affective disorders: relevance for drug development.CNSNeurosci Ther 2008; 14:2-9.
Cassano P, Fava M. Depression and public health: an overview. J Psychosom Res 2002;53:849-57.
Kirmayer LJ, Robbins JM, Dworkind M, Yaffe MJ. Somatization and the recognition of depression and anxiety in primary care. Am J Psychiatry 1993;150:734-41.
Fava M. Somatic symptoms, depression, and antidepressant treatment. J Clin Psychiatry 2002;63:305-7.
Andreasen NC. DSM and the death of phenomenology in America: an example of unintended consequences. Schizophr Bull 2007; 33:108-12.